RECENT DEVELOPMENT IN TREATMENT FOR NON SMALL CELL LUNG CANCER A REVIEW
Ph.D Scholar, Department of Pharmaceutics, Osmania University College of Technology, Osmania University, Hyderabad, Telangana – 500007, India
K.Satyanarayana
Professor and Principal, Department of Pharmacognosy, Princeton College of Pharmacy, Korremula, Ghatkesar, R.R. District, Telangana-500088, India
Prakash Kumar Nayak
Clinical Operation Department, Apotex Research Private Limited, Bangalore, Karnataka - 560099, India
Kishan Ranjan Sahoo
Sitec Labs Pvt. Ltd., Pee Dee Info Tech, Navi Mumbai, Maharastra-400701, India
Mrutyunjay Champati
Drug safety Associate, Synowledge PV Services Pvt. Ltd. Mysore, Karnataka, India
The lungs are vital organs. Working with the heart and circulatory system, they provide life-sustaining oxygen and rid the body of carbon dioxide. Normal lungs have a great reserve capacity to meet the body’s need for oxygen across a wide variety of circumstances. The same is true of the heart and circulatory system. This reserve capacity permits cancerous lung tumors to grow for years without compromising lung function. Furthermore, the lungs do not have many nerves to transmit pain messages. Therefore, a cancerous lung tumor can grow for many years without causing any symptoms.Lungs cancer is the fatal diease in worldwide.The prognosis of lungs cancer is generally favorable. Non small cell lungs cancer is regarded as life threatening disease occurred mostly than other types.Hence early diagnosis and quick treatment is essential. Normally surgery, radiation therapy and chemotherapy allow a good prognosis for non small cell lungs cancer
6 , 1 , 2016
7 - 23
Subscriber Login
